[1] 中华医学会消化病学分会胃肠激素与神经内分泌肿瘤学组.胃肠胰神经内分泌肿瘤诊治专家共识(2020·广州).中华消化杂志,2021,41(2):76-87.
[2] Gay-Chevallier S, de Mestier L, Perinel J, et al. Management and prognosis of localized duodenal neuroendocrine neoplasms. Neuroendocrinology, 2021,111(8):718-727.
[3] Clift AK, Kidd M, Bodei L, et al. Neuroendocrine neoplasms of the small bowel and pancreas. Neuroendocrinology, 2020,110(6):444-476.
[4] Han X, Zhong H, Hong D, et al. Elevated procalcitonin levels in primary hepatic neuroendocrine carcinoma: case report and literature review. Medicine, 2020, 99(31):e21210.
[5] 王慧,刘勤江,王云生.甲状腺髓样癌中降钙素和降钙素原的表达及临床意义.兰州大学学报(医学版),2020,46(4):25-29.
[6] Hu Q, Jin P, Zhao X, et al. Esophageal neuroendocrine carcinoma complicated with unexpected hyperprocalcitonin: case report and literature review. Medicine, 2018, 97(40):e12219.
[7] 中华医学会病理学分会消化疾病学组,2020年中国胃肠胰神经内分泌肿瘤病理诊断共识专家组.中国胃肠胰神经内分泌肿瘤病理诊断共识(2020版).中华病理学杂志,2021,50(1):14-20. |
